Teleflex Incorporated (NYSE:TFX) Shares Acquired by BNP Paribas Financial Markets

BNP Paribas Financial Markets grew its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 35.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,735 shares of the medical technology company's stock after purchasing an additional 10,405 shares during the period. BNP Paribas Financial Markets owned about 0.08% of Teleflex worth $9,908,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Venturi Wealth Management LLC boosted its position in Teleflex by 33.3% during the 4th quarter. Venturi Wealth Management LLC now owns 184 shares of the medical technology company's stock worth $46,000 after buying an additional 46 shares during the period. Huntington National Bank raised its holdings in Teleflex by 26.5% during the 3rd quarter. Huntington National Bank now owns 253 shares of the medical technology company's stock worth $50,000 after purchasing an additional 53 shares during the last quarter. Lindbrook Capital LLC raised its holdings in Teleflex by 75.3% during the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company's stock worth $34,000 after purchasing an additional 58 shares during the last quarter. Wahed Invest LLC raised its holdings in Teleflex by 10.4% during the 3rd quarter. Wahed Invest LLC now owns 733 shares of the medical technology company's stock worth $144,000 after purchasing an additional 69 shares during the last quarter. Finally, Treasurer of the State of North Carolina raised its holdings in Teleflex by 0.3% during the 3rd quarter. Treasurer of the State of North Carolina now owns 21,892 shares of the medical technology company's stock worth $4,300,000 after purchasing an additional 72 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Stock Down 0.4 %

NYSE TFX traded down $0.93 during mid-day trading on Friday, hitting $217.64. The company's stock had a trading volume of 392,883 shares, compared to its average volume of 306,818. The company's 50 day simple moving average is $214.15 and its 200 day simple moving average is $227.40. Teleflex Incorporated has a twelve month low of $177.63 and a twelve month high of $262.97. The company has a current ratio of 2.51, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $10.25 billion, a price-to-earnings ratio of 34.93, a PEG ratio of 2.13 and a beta of 1.13.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.07 by $0.14. The business had revenue of $737.80 million during the quarter, compared to the consensus estimate of $726.85 million. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. Teleflex's revenue was up 3.8% compared to the same quarter last year. During the same quarter last year, the firm posted $3.09 EPS. Analysts anticipate that Teleflex Incorporated will post 13.75 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Wednesday, May 15th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.62%. The ex-dividend date of this dividend is Tuesday, May 14th. Teleflex's dividend payout ratio is 21.83%.

Analysts Set New Price Targets

Several research analysts have issued reports on TFX shares. Royal Bank of Canada lowered their price target on shares of Teleflex from $272.00 to $265.00 and set an "outperform" rating for the company in a report on Friday, February 23rd. Truist Financial lowered their price target on shares of Teleflex from $240.00 to $219.00 and set a "hold" rating for the company in a report on Friday, May 3rd. StockNews.com lowered shares of Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 23rd. JMP Securities reiterated a "market outperform" rating and issued a $285.00 price objective on shares of Teleflex in a research note on Friday, February 23rd. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a research note on Friday, May 3rd. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, Teleflex currently has a consensus rating of "Moderate Buy" and an average target price of $261.75.

Insiders Place Their Bets

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of Teleflex stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total transaction of $1,665,225.00. Following the transaction, the vice president now directly owns 10,050 shares of the company's stock, valued at approximately $2,261,250. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.43% of the company's stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.